Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH)

T. Meyer, R. Finn, M. Kudo, Y. Kang, C. Yen, P. Galle, J. Llovet, E. Assenat, G. Brandi, K. Motomura, T. Okusaka, R. Hubner, M. Karwal, A. Baron, M. Ikeda, K. Liang, C. Wang, R. Widau, W. Schelman, A. Zhu

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)iv133
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Publication statusPublished - 2019 Jul 1

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this